Tue Jul 22 17:17:28 SGT 2014  
    Botox® Face Slimming, Puerto Rico

Botox® Face Slimming, Puerto Rico

Summary

Botox® Face Slimming, Puerto Rico @beautypuertorico_com: Botox® Cosmetic, Dysport®, BTX-A, botulinum toxin type A injection, wrinkle removal treatment clinic, Puerto Rico. Cost/price for treating glabella frown lines, crow's feet, and horizontal forehead lines. Definitions, references, and latest news.

Keywords: Botox Face Slimming Puerto Rico, Puerto Rico Botox Face Slimming, Botox Face Slimming.

Description

Botox® is one of the trade names for botulinum toxin, which is a protein produced by the bacterium clostridium botulinum.

Botox® price. Average Botox® cost.

AreaIU/spotSpotsTotal IUPrice @ SG$15/IU
Horizontal forehead lines2816SG$240
Glabellar frown lines4520SG$300
Crow's feet4624SG$360
ConsultationSG$38
TotalSG$938

Jaw reduction / jaw slimming / face slimming / Botox® jaw reduction / Botox® jaw slimming / Botox® face slimming price.

AreaIU/spotSpotsTotal IUPrice @ SG$15/IU
Jaw reduction8 to 12656SG$840
ConsultationSG$38
TotalSG$878

Botox® treatment is with the original Allergan Botox® Cosmetic

  • The units differ for different brands.
  • Price quoted is for average ladies face, with average musculature.
  • Muscular men might require up to twice as much.
  • Minimum charge is for 10 units.

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Botox® Face Slimming, Puerto Rico
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

Big Allergan Investor Sells Most of Stake
Mon, 21 Jul 2014 11:15:20 +0100 | WSJ.com: Health
Allergan shareholder Capital Research and Management has sold nearly all of its holdings in the Botox maker's stock amid Valeant's takeover attempt. (Source: WSJ.com: Health)

'Botox can ease shingles agony': Anti-wrinkle drug found to be effective treatment of nerve pain
Sat, 05 Jul 2014 22:08:08 +0100 | the Mail online | Health
Botox was found to be more effective than the anaesthetic lidocaine when extreme nerve pain continues after a shingles rash has healed. (Source: the Mail online | Health)

Treatment of interstitial cystitis/painful bladder syndrome as a neuropathic pain condition
Tue, 01 Jul 2014 00:00:00 +0100 | Indian Journal of Urology
Lakshmi Vas, Manorama Pattanik, Vaishali TitarmoreIndian Journal of Urology 2014 30(3):350-353A lady of 52 years with painful bladder syndrome/interstitial cystitis (PBS/IC) presented with chronic pelvic pain, irritative voiding with sphincter dominance on urodynamics. 3 yrs of oral analgesics, antispasmodics and intravesical therapy was ineffective. We surmised her pain, and irritative voiding to be secondary to constant straining against a dysfunctional pelvic floor. We treated PBS/IC as a neuropathic phenomenon with a combination of neuromodulator medications and continuous caudal epidural analgesia to reduce the pain induced peripheral and central sensitisation. Botulinum toxin type A injection into pelvic floor muscles appeared to address their dysfuction. Clinical and urodynamics res...

Change of distribution and timing of bite force after botulinum toxin type a injection evaluated by a computerized occlusion analysis system.
Sat, 28 Jun 2014 23:40:25 +0100 | Yonsei Medical Journal
CONCLUSION: A decline in the difference in the clenching force between the left and right sides was found with increasing time up to 12 weeks following BTX-A injection.

Report: Another activist investor pressures Allergan to sell
Fri, 27 Jun 2014 17:25:32 +0100 | Mass Device
Another hedge fund buys a massive stake in Botox-maker Allergan, throwing its support behind Valeant Pharmaceuticals' unrequited acquisition bid, according to a report.

Merz buying Mesa medical device company Ulthera for $600M
Thu, 26 Jun 2014 21:50:00 +0100 | bizjournals.com Health Care:Pharmaceuticals headlines
Merz, the German pharmaceutical company Merz that has its U.S.headquarters in North Carolina, has agreed to buy Arizona medical device company Ulthera for $600 million in upfront cash and milestone payments.

Merz buying medical device company Ulthera for $600M
Thu, 26 Jun 2014 21:21:00 +0100 | bizjournals.com Health Care:Pharmaceuticals headlines
Merz, the German pharmaceutical company Merz that has its U.S.headquarters in High Point, has agreed to buy Arizona medical device company Ulthera for $600 million in upfront cash and milestone payments.

Allergan Turns Down Valeant's Merger Offer
Wed, 25 Jun 2014 11:36:38 +0100 | Pharmaceutical Online News
After reviewing Valeant’s takeover proposal last week, Allergan today announced it has deemed the offer “grossly inadequate,” leading the botox maker’s board turned down the bid in a unanimous vote. (Source: Pharmaceutical Online News)

More Evidence Botox Works for Depression
Mon, 23 Jun 2014 07:00:00 +0100 | eMedicineHealth.com
(Source: eMedicineHealth.com)

[Cost analysis of the use of botulinum toxin type A in Spain.]
Sun, 22 Jun 2014 10:20:06 +0100 | Farmacia Hospitalaria
Conclusions: The appropriate BoNT-A choice would lead to considerablesavings for the National Health System. Botox® would generatelower costs per patient than other BoNT-A products in 9 out of 12 scenariosconsidered.